Cytotoxic T cell-mediated diabetes in RIP-CD80 transgenic mice: Autoantigen peptide sensitivity and fine specificity

Annals of the New York Academy of Sciences

Volumn 1103, Issue , 2007, Pages 132-142

  Pechhold, Klaus ^a   Chakrabarty, Sagarika ^a   Harlan, David M ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Altered peptide ligands; Autoantigen induced diabetes; Autoimmunity; Cytotoxic T lymphocytes; Immunization; Transgenic mouse

Indexed keywords

AUTOANTIGEN; B7 ANTIGEN; DENDRITIC CELL VACCINE; EPITOPE; INSULIN; PEPTIDE DERIVATIVE; PREPROINSULIN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS; MUS MUSCULUS; RATTUS; RODENTIA;

EID: 34249037425     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1394.008     Document Type: Article

References (23)

1. EISENBARTH, G.S. 2003. Insulin autoimmunity: immunogenetics/immunopathogenesis of type 1A diabetes. Ann. N. Y. Acad. Sci. 1005: 109-118.
2. + T cell response. Ann. N. Y. Acad. Sci. 1005: 88-97.
3. SERCARZ, E.E. 2000. Driver clones and determinant spreading. J. Autoimmun. 14: 275-277.
4. HARLAN, D.M., H. HENGARTNER, M.L. HUANG, et al. 1994. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta-cells along with glycoprotein-specific transgenic T-cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc. Natl. Acad. Sci. USA 91: 3137-3141.
5. HARLAN, D.M., M.A. BARNETT, R. ABE, et al. 1995. Very-low-dose streptozotocin induces diabetes in insulin promoter-mB7-1 transgenic mice. Diabetes 44: 816-823.
6. VON HERRATH, M.G., S. GUERDER, H. LEWICKI, et al. 1995. Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 3: 727-738.
7. GUERDER, S., D.E. PICARELLA, P.S. LINSLEY, et al. 1994. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA 91: 5138-5142.
8. MORIYAMA, H., L. WEN, N. ABIRU, et al. 2002. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc. Natl. Acad. Sci. USA 99: 5539-5544.
9. PECHHOLD, K., N.B. PATTERSON, C. BLUM, et al. 2001. Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent. J. Immunol. 166: 2531-2539.
10. PECHHOLD, K., W. KARGES, C. BLUM, et al. 2003. Beta cell-specific CD80 (B7-1) expression disrupts tissue protection from autoantigen-specific CTL-mediated diabetes. J. Autoimmun. 20: 1-13.
11. KARGES, W., K. PECHHOLD, S. AL DAHOUK, et al. 2002. Induction of autoimmune diabetes through insulin (but not GAD65)DNAvaccination in nonobese diabetic and in RIP-B7.1 mice. Diabetes 51: 3237-3244.
12. WONG, F.S., J. KARTTUNEN, C. DUMONT, et al. 1999. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 5: 1026-1031.
13. SERCARZ, E.E. 1998. Immune focusing vs diversification and their connection to immune regulation. Immunol. Rev. 164: 5-10.
14. SHEIL, J.M., S.E. SHEPHERD, G.F. KLIMO, et al. 1992. Identification of an autologous insulin B chain peptide as a target antigen for H-2Kb-restricted cytotoxic T lymphocytes. J. Exp. Med. 175: 545-552.
15. +-autoreactive CTL expressing both type 1 and type 2 cytokines in C57BL/6 mice. J. Immunol. 164: 86-92.
16. SEBZDA, E., T.M. KUENDIG, C.T. THOMSON, et al. 1996. Mature T cell reactivity altered by peptide agonist that induces positive selection. J. Exp. Med. 183: 1093-1104.
17. BACHMANN, M.F., D.E. SPEISER & P.S. OHASHI. 1997. Functional maturation of an antiviral cytotoxic T-cell response. J. Virol. 71: 5764-5768.
18. RAMMENSEE, H., J. BACHMANN, N.P. EMMERICH, et al. 1999. SYFPEITHI: database for MHC ligands and peptide motifs Immunogenetics 50: 213-219.
19. DAVIES, J.M. 1997. Molecular mimicry: can epitope mimicry induce autoimmune disease? Immun. Cell. Biol. 75: 113-126.
20. LUDEWIG, B., B. ODERMATT, S. LANDMANN, et al. 1998. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J. Exp. Med. 188: 1493-1501.
21. PIRCHER, H., K. BURKI, R. LANG, et al. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342: 559-561.
22. PIRCHER, H., K. BRDUSCHA, U. STEINHOFF, et al. 1993. Tolerance induction by clonal deletion of CD4 + 8+ thymocytes in vitro does not require dedicated antigen-presenting cells. Eur. J. Immunol. 23: 669-674.
23. GAIRIN, J.E., H. MAZARGUIL, D. HUDRISIER, et al. 1995. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J. Virol. 69: 2297-2305.